G Medical Innovations Holdings (G Medical Innovations Holdings) Cash And Cash Equivalents : $0.30 Mil (As of Dec. 2022)

View and export this data going back to 2017. Start your Free Trial

What is G Medical Innovations Holdings Cash And Cash Equivalents?

G Medical Innovations Holdings's quarterly cash and cash equivalents declined from Dec. 2021 ($6.03 Mil) to Jun. 2022 ($1.51 Mil) but then stayed the same from Jun. 2022 ($1.51 Mil) to Dec. 2022 ($0.30 Mil).

G Medical Innovations Holdings's annual cash and cash equivalents increased from Dec. 2020 ($0.28 Mil) to Dec. 2021 ($6.03 Mil) but then declined from Dec. 2021 ($6.03 Mil) to Dec. 2022 ($0.30 Mil).

G Medical Innovations Holdings Cash And Cash Equivalents Historical Data

The historical data trend for G Medical Innovations Holdings's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G Medical Innovations Holdings Cash And Cash Equivalents Chart

G Medical Innovations Holdings Annual Data

Trend

Sep16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Cash And Cash Equivalents

Get a 7-Day Free Trial

3.35

0.72

0.28

6.03

0.30

G Medical Innovations Holdings Semi-Annual Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22
Cash And Cash Equivalents	Get a 7-Day Free Trial							0.28	13.38	6.03	1.51	0.30

G Medical Innovations Holdings Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

G Medical Innovations Holdings (OTCPK:GMVDF) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

G Medical Innovations Holdings Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of G Medical Innovations Holdings's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

G Medical Innovations Holdings (G Medical Innovations Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » G Medical Innovations Holdings Ltd (OTCPK:GMVDF) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

5 Oppenheimer Street, Rehovot, ISR, 7670105

Website

https://www.gmedinnovations.com

G Medical Innovations Holdings Ltd is a mobile health (mHealth), telemedicine solutions, and monitoring service platforms. It develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. The company offers a suite of both consumer and clinical grade products and platforms which are positioned to reduce inefficiencies in healthcare delivery, improve access, reduce costs, increase the quality of care, and make healthcare more personalized and precise. Its operating segment includes Products, Patient Services, and Covid-19 testing. The company generates maximum revenue from the Patient Services segment.

Executives

Awm Investment Company, Inc.

10 percent owner

527 MADISON AVENUE, SUITE 2600, NEW YORK NY 10022